Literature DB >> 2230647

Suppression of developmental anomalies by maternal macrophages in mice.

T Nomura1, S Hata, T Kusafuka.   

Abstract

We tested whether nonspecific tumoricidal immune cells can suppress congenital malformations by killing precursor cells destined to cause such defects. Pretreatment of pregnant ICR mice with synthetic (Pyran copolymer) and biological (Bacillus Calmette-Guérin) agents significantly suppressed radiation- and chemical-induced congenital malformations (cleft palate, digit anomalies, tail anomalies, etc.). Such suppressive effects were associated with the activation of maternal macrophages by these agents, but were lost either after the disruption of activated macrophages by supersonic waves or by inhibition of their lysosomal enzyme activity with trypan blue. These results indicate that a live activated macrophage with active lysosomal enzymes can be an effector cell to suppress maldevelopment. A similar reduction by activated macrophages was observed in strain CL/Fr, which has a high spontaneous frequency of cleft lips and palates. Furthermore, Pyran-activated maternal macrophages could pass through the placenta, and enhanced urethane-induced cell killing (but not somatic mutation) in the embryo. It is likely that a maternal immunosurveillance system eliminating preteratogenic cells allows for the replacement with normal totipotent blast cells during the pregnancy to protect abnormal development.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2230647      PMCID: PMC2188678          DOI: 10.1084/jem.172.5.1325

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  Fertilizing ability of mouse sperm from different epididymal regions and after washing and centrifugation.

Authors:  P C Hoppe
Journal:  J Exp Zool       Date:  1975-05

2.  Association of macrophage activation with antitumor activity by synthetic and biological agents.

Authors:  R M Schultz; J D Papamatheakis; J Luetzeler; M A Chirigos
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

3.  Inhibiting effects of nicotinamide on urethane-induced malformations and tumors in mice.

Authors:  H Gotoh; T Nomura; H Nakajima; C Hasegawa; Y Sakamoto
Journal:  Mutat Res       Date:  1988-05       Impact factor: 2.433

4.  Histological study of cell death in digital malformations induced by 5-azacytidine: suppressive effect of caffeine.

Authors:  A Kurishita
Journal:  Teratology       Date:  1989-02

5.  Maternal and fetal distribution of drugs in pregnancy.

Authors:  B L Mirkin
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

6.  An approach towards to standardization of the mammalian spot test.

Authors:  A Neuhäuser-Klaus
Journal:  Arch Toxicol       Date:  1981-11       Impact factor: 5.153

7.  Comparative inhibiting effects of methylxanthines on urethan-induced tumors, malformations, and presumed somatic mutations in mice.

Authors:  T Nomura
Journal:  Cancer Res       Date:  1983-03       Impact factor: 12.701

8.  Killing of preimplantation mouse embryos by main ingredients of cleansers AS and LAS.

Authors:  T Nomura; S Hata; K Shibata; T Kusafuka
Journal:  Mutat Res       Date:  1987-01       Impact factor: 2.433

9.  Antiteratogenic effects of tumor inhibitors, caffeine, antipain, and retinoic acid in mice.

Authors:  T Nomura; T Enomoto; K Shibata; T Kanzaki; H Tanaka; S Hata; S Kimura; T Kusafuka; K Sobue; S Miyamoto
Journal:  Cancer Res       Date:  1983-11       Impact factor: 12.701

10.  Similarity of the mechanism of chemical carcinogen-initiated teratogenesis and carcinogenesis in mice.

Authors:  T Nomura
Journal:  Cancer Res       Date:  1977-04       Impact factor: 12.701

View more
  9 in total

Review 1.  The role of apoptosis in normal and abnormal embryonic development.

Authors:  A Brill; A Torchinsky; H Carp; V Toder
Journal:  J Assist Reprod Genet       Date:  1999-11       Impact factor: 3.412

2.  Reduction in diabetes-induced craniofacial defects by maternal immune stimulation.

Authors:  Terry C Hrubec; M Renee Prater; Kimberly A Toops; Steven D Holladay
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2006-02

3.  Effect of the dam strain on the spontaneous incidence of cleft lip and palate and intrauterine growth of CL/Fr mouse fetuses.

Authors:  K Nonaka; Y Sasaki; D A Martin; M Nakata
Journal:  J Assist Reprod Genet       Date:  1995-08       Impact factor: 3.412

4.  Reduction in valproic acid-induced neural tube defects by maternal immune stimulation: role of apoptosis.

Authors:  Mural Mallela; Theresa Hrubec
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2012-07-05

5.  Maternal serum CFHR4 protein as a potential non-invasive marker of ventricular septal defects in offspring: evidence from a comparative proteomics study.

Authors:  Jing He; Liang Xie; Li Yu; Lijun Liu; Hong Xu; Tao Wang; Yuyang Gao; Xuedong Wang; You Duan; Hanmin Liu; Li Dai
Journal:  Clin Proteomics       Date:  2022-05-19       Impact factor: 5.000

6.  Valproic acid-induced fetal malformations are reduced by maternal immune stimulation with granulocyte-macrophage colony-stimulating factor or interferon-gamma.

Authors:  Terry C Hrubec; Mingjin Yan; Keying Ye; Carolyn M Salafia; Steven D Holladay
Journal:  Anat Rec A Discov Mol Cell Evol Biol       Date:  2006-12

7.  Placental oxidative stress alters expression of murine osteogenic genes and impairs fetal skeletal formation.

Authors:  M R Prater; C L Laudermilch; C Liang; S D Holladay
Journal:  Placenta       Date:  2008-09       Impact factor: 3.481

8.  Modulation of diabetes-induced palate defects by maternal immune stimulation.

Authors:  Terry C Hrubec; Kimberly A Toops; Steven D Holladay
Journal:  Anat Rec (Hoboken)       Date:  2009-02       Impact factor: 2.064

9.  Pregnancy outcome in ethanol-treated mice with folic acid supplementation in saccharose.

Authors:  M Y Yanaguita; C M Gutierrez; C N M Ribeiro; G A Lima; H R Machado; L C Peres
Journal:  Childs Nerv Syst       Date:  2007-07-10       Impact factor: 1.475

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.